Herpes viruses in the brain linked to Alzheimer's disease

New Scientist

The most in-depth analysis of human brain tissue ever done in Alzheimer's disease has found evidence for the controversial theory that viruses play a role in the condition. If true, it could mean that some instances of Alzheimer's might be treated with anti-viral drugs. Alzheimer's is the most common cause of dementia, affecting some 47 million people worldwide.


Alzheimer's Algorithm May Predict Who Gets the Disease

#artificialintelligence

Alzheimer's disease has no cure, but getting a diagnosis as quickly as possible can allow patients to start symptom-delaying drugs. The problem with getting that diagnosis, though, is that the early stages of Alzheimer's can look a lot like mild cognitive impairment, which may or may not progress into Alzheimer's.


?utm_content=bufferfef66&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

#artificialintelligence

Out of the total number, 48 were scans of people with the disease, while 48 were scans of people who suffered from mild cognitive impairment and eventually developed full-blown Alzheimer's. The AI was able to diagnose Alzheimer's 86 percent of the time. More importantly, it was able to detect mild cognitive impairment 84 percent of the time, making it a potentially effective tool for early diagnosis. With more samples and further development, though, the AI could become more accurate until it's reliable enough to be used as a non-invasive early detection system.


Alzheimer's and AI: How Technology Can Help with Diagnosis and Treatment - Being Patient

#artificialintelligence

Being Patient talks to Dr. John Walker, who founded uMETHOD Health, the first company that is using precision medicine and AI to help treat Alzheimer's, about how technology could diagnose and prevent cognitive decline.


Does Alzheimer's Unfold Differently in Black Patients?

U.S. News

"If we want to understand all the ways the disease can develop in people, we need to include people from all groups. Without a complete understanding of the illness, we're not going to be able to develop therapies that work for all people," Morris said.